Tonix Pharmaceuticals Holding Corp.

( )
TNXP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
SAVACassava Sciences, Inc. -2.07%53.490.0%$435.88m
HZNPHorizon Therapeutics Plc 1.65%103.765.4%$197.51m
CTLTCatalent, Inc. -3.95%128.672.0%$140.45m
VRXValeant Pharmaceuticals International, Inc. -4.49%23.8314.1%$140.22m
ICLRICON plc -2.03%270.472.8%$113.03m
UTHRUnited Therapeutics Corp. -2.32%189.5013.9%$79.26m
JAZZJazz Pharmaceuticals Plc -2.08%119.872.1%$71.81m
BHCBausch Health Cos., Inc. -4.49%23.830.0%$71.24m
PRGOPerrigo Co. Plc -2.05%36.716.9%$55.85m
CPIXCumberland Pharmaceuticals, Inc. 128.64%5.030.6%$53.21m
ARGXargenx SE 1.05%279.210.0%$53.10m
ENDPEndo International Plc -4.11%5.608.5%$51.98m
QLGNQualigen Therapeutics, Inc. -6.96%1.470.0%$27.60m
AXSMAxsome Therapeutics, Inc. 0.58%34.541.8%$24.89m
IRWDIronwood Pharmaceuticals, Inc. 2.12%11.099.5%$24.26m

Company Profile

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.